As Coronavirus Tightens Its Grip, US FDA Cancels Some Meetings Due To ‘Extenuating Circumstances’
Agency won't say whether patient-focused drug development meeting and gene therapy conference were postponed because of COVID-19, but other meetings remain as scheduled.
You may also be interested in...
Productivity may suffer under coronavirus-mandated telework despite workforce diligence, experts say.
Sponsors have been asked to switch to teleconferences with FDA staff as the agency prepares for more of its employees to work from home.
In addition to postponing NDAC meeting on food handler antiseptic drug products, FDA is suspending most inspections of foreign manufacturing facilities through April. Latest consumer health industry conferences cancelled or postponed are Consumer Healthcare Product Association and Informa Markets events.